Log in or Sign up for Free to view tailored content for your specialty!
Psoriatic Disease News
Bimekizumab results in rapid, sustained improvements to PsA patient reported outcomes
Bimekizumab treatment for psoriatic arthritis demonstrated rapid, clinically meaningful improvements to patient reported outcomes that were sustained up to 1 year, according to data published in Rheumatology.
Treatment advancements merit updates to dermatological disqualifiers in the military
Due to medical advancements, researchers are calling for an update to the U.S. Department of Defense’s policies restricting individuals with psoriasis and atopic dermatitis from joining and remaining in the military, according to a study.
Log in or Sign up for Free to view tailored content for your specialty!
Extensive psoriasis, IBD history predict difficult-to-treat psoriatic arthritis
Difficult-to-treat psoriatic arthritis was common in a large, real-life cohort, with key risk factors including extensive psoriasis, higher BMI and a history of inflammatory bowel disease, according to data published in Rheumatology.
Targeted psoriatic arthritis therapies demonstrate low risk for serious infection
Serious infections were uncommon among patients with psoriatic arthritis exposed to targeted therapies for the first time in “a large and exhaustive” French cohort, according to data published in RMD Open.
VIDEO: Dermatologists, rheumatologists share care in psoriasis, psoriatic arthritis
CLEVELAND — Dermatology and rheumatology often work together in the treatment of psoriasis and psoriatic arthritis.
FDA approves Rinvoq for JIA, psoriatic arthritis in children aged 2 years and older
The FDA has expanded the indication of Rinvoq to include active, polyarticular juvenile idiopathic arthritis and psoriatic arthritis in children aged 2 years and older, according to an AbbVie press release.
With abundant psoriasis treatments available, research now aiming for higher goals
CLEVELAND — With myriad treatment options now available for psoriasis vulgaris, recent research is focusing on reaching higher goals, Anthony P. Fernandez, MD, PhD, said at the Medical Dermatology Therapy Update III meeting.
Stress may be associated with increased risk of psoriasis among men
Low stress resilience in men may be linked to an increased risk for developing psoriasis or psoriatic arthritis, according to a study.
IL-17 inhibitors may break TNFi ‘glass ceiling’ in psoriatic arthritis prescribing
Although TNF inhibitors remain the first choice biologic for many rheumatologists treating psoriatic arthritis, interleukin-17 inhibitors may soon overtake them, according to a market analysis from Spherix Global Insights.
Simlandi launches in U.S. as third interchangeable Humira biosimilar
Simlandi injection, an interchangeable biosimilar to Humira, is now available in the U.S. for the treatment of psoriatic arthritis, plaque psoriasis and other conditions, Teva Pharmaceuticals and Alvotech announced in a press release.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read